Omega-3 fatty acids in the treatment of psychiatric disorders (Q28251943)

https://scigraph.springernature.com/pub.10.2165/00003495-200565080-00002

Europe PubMed Central

title

Omega-3 fatty acids in the treatment of psychiatric disorders (English)

0 references

0 references

Malcolm Peet

1

0 references

Caroline Stokes

series ordinal

2

0 references

language of work or name

English

0 references

publication date

2005

0 references

published in

Drugs

0 references

volume

65

0 references

page(s)

1051-9

0 references

issue

8

0 references

exact match

0 references

cites work

Fish consumption and major depression.

1 reference

12 December 2020

Is low dietary intake of omega-3 fatty acids associated with depression?

1 reference

12 December 2020

Fat consumption and schizophrenia.

1 reference

12 December 2020

Dietary sugar and polyunsaturated fatty acid consumption as predictors of severity of schizophrenia symptoms

1 reference

12 December 2020

Mechanisms of action of docosahexaenoic acid in the nervous system

1 reference

12 December 2020

Effect of docosahexaenoic acid-containing food administration on symptoms of attention-deficit/hyperactivity disorder - a placebo-controlled double-blind study

1 reference

12 December 2020

Red blood cell membrane dynamics in schizophrenia. II. Fatty acid composition

1 reference

12 December 2020

Essential fatty acids in health and chronic disease

1 reference

12 December 2020

Omega-3 polyunsaturated fatty acid levels in the diet and in red blood cell membranes of depressed patients

1 reference

12 December 2020

Docosahexaenoic acid and cerebral evolution

1 reference

12 December 2020

A randomized double-blind, placebo-controlled study of the effects of supplementation with highly unsaturated fatty acids on ADHD-related symptoms in children with specific learning difficulties.

1 reference

12 December 2020

The effect of docosahexaenoic acid on aggression in elderly Thai subjects--a placebo-controlled double-blind study

1 reference

12 December 2020

Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial

1 reference

12 December 2020

Inhibitory effects of omega-3 fatty acids on protein kinase C activity in vitro.

1 reference

12 December 2020

1 reference

12 December 2020

Two double-blind placebo-controlled pilot studies of eicosapentaenoic acid in the treatment of schizophrenia

1 reference

12 December 2020

The role of fish oils in the treatment of rheumatoid arthritis

1 reference

12 December 2020

Fish consumption and self-reported physical and mental health status

1 reference

12 December 2020

A placebo-controlled trial of omega-3 fatty acid (ethyl eicosapentaenoic acid) supplementation for residual symptoms and cognitive impairment in schizophrenia

1 reference

12 December 2020

Fish consumption and depressive symptoms in the general population in Finland.

1 reference

12 December 2020

Role of essential fatty acids in the function of the developing nervous system

1 reference

12 December 2020

A dose-ranging exploratory study of the effects of ethyl-eicosapentaenoate in patients with persistent schizophrenic symptoms

1 reference

12 December 2020

Alpha-linolenic acid metabolism in men and women: nutritional and biological implications.

1 reference

12 December 2020

How blind is double-blind? A study of fish oil versus placebo

1 reference

12 December 2020

Immunity and schizophrenia: autoimmunity, cytokines, and immune responses

1 reference

12 December 2020

A placebo-controlled cross-over trial of adjunctive EPA in OCD.

1 reference

12 December 2020

Causes of the excess mortality of schizophrenia

1 reference

12 December 2020

Omega-3 fatty acids in major depressive disorder. A preliminary double-blind, placebo-controlled trial.

1 reference

12 December 2020

International variations in the outcome of schizophrenia and the prevalence of depression in relation to national dietary practices: an ecological analysis

1 reference

12 December 2020

EFA supplementation in children with inattention, hyperactivity, and other disruptive behaviors

1 reference

12 December 2020

The major psychoses and neuroses as omega-3 essential fatty acid deficiency syndrome: substrate pellagra.

1 reference

12 December 2020

Polyunsaturated fatty acid levels in red cell membranes of unmedicated schizophrenic patients

1 reference

12 December 2020

Fish consumption and depression: the Northern Finland 1966 birth cohort study

1 reference

12 December 2020

The effect of docosahexaenoic acid on aggression in young adults. A placebo-controlled double-blind study

1 reference

12 December 2020

Benefits and risks of folic acid to the nervous system

1 reference

12 December 2020

Essential fatty acids, lipid membrane abnormalities, and the diagnosis and treatment of schizophrenia

1 reference

12 December 2020

Folate and homocysteine metabolism in neural plasticity and neurodegenerative disorders

1 reference

12 December 2020

Fish, meat, and risk of dementia: cohort study

1 reference

12 December 2020

omega-3 Fatty acid treatment of women with borderline personality disorder: a double-blind, placebo-controlled pilot study

1 reference

12 December 2020

Optimal diets for prevention of coronary heart disease

1 reference

12 December 2020

A Double-Blind, Placebo-Controlled Study of the Omega-3 Fatty Acid Docosahexaenoic Acid in the Treatment of Major Depression

1 reference

12 December 2020

Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease

1 reference

12 December 2020

Beneficial antipsychotic effects of celecoxib add-on therapy compared to risperidone alone in schizophrenia

1 reference

12 December 2020

A red cell membrane abnormality in a subgroup of schizophrenic patients: evidence for two diseases.

1 reference

12 December 2020

Depression and cardiac mortality: results from a community-based longitudinal study

1 reference

12 December 2020

Seafood consumption, the DHA content of mothers' milk and prevalence rates of postpartum depression: a cross-national, ecological analysis

1 reference

12 December 2020

Fatty acid levels in the brains of schizophrenics and normal controls.

1 reference

12 December 2020

Seafood consumption and homicide mortality. A cross-national ecological analysis.

1 reference

12 December 2020

Polyunsaturated fatty acids, inflammation, and immunity.

1 reference

12 December 2020

Long-term effects of n-3 polyunsaturated fatty acids on haemostatic variables and bleeding episodes in patients with coronary artery disease

1 reference

12 December 2020

Low serum folate concentrations are associated with an excess incidence of acute coronary events: the Kuopio Ischaemic Heart Disease Risk Factor Study

1 reference

12 December 2020

The role of n-3 polyunsaturated fatty acids in brain: modulation of rat brain gene expression by dietary n-3 fatty acids

1 reference

12 December 2020

Depleted red cell membrane essential fatty acids in drug-treated schizophrenic patients

1 reference

12 December 2020

Dietary essential fatty acids and brain function: a developmental perspective on mechanisms

1 reference

12 December 2020

Fish oil in people with type 2 diabetes mellitus

1 reference

12 December 2020

Fish oil and glycemic control in diabetes. A meta-analysis

1 reference

12 December 2020

A randomized, double-blind, placebo-controlled trial of docosahexaenoic acid supplementation in children with attention-deficit/hyperactivity disorder

1 reference

12 December 2020

Molecular recognition of fatty acids by peroxisome proliferator-activated receptors

1 reference

12 December 2020

Cross-national comparisons of seafood consumption and rates of bipolar disorders

1 reference

12 December 2020

Randomized, placebo-controlled study of ethyl-eicosapentaenoic acid as supplemental treatment in schizophrenia

1 reference

12 December 2020

Addition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder

1 reference

12 December 2020

A dose-ranging study of the effects of ethyl-eicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs

1 reference

12 December 2020